Review
doi: 10.1055/s-0030-1247864.
Epub 2010 Jan 26.
[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?]
[Article in
German]
Affiliations
- PMID: 20104442
- DOI: 10.1055/s-0030-1247864
Item in Clipboard
Review
[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?]
[Article in
German]
Dtsch Med Wochenschr.
2010 Feb.
No abstract available
Similar articles
-
Dabigatran: new drug. Continue to use heparin, a better-known option.Prescrire Int. 2009 Jun;18(101):97-9. Prescrire Int. 2009. PMID: 19637411
-
Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:9S-16S. doi: 10.1177/1076029609343004. Epub 2009 Aug 19. Clin Appl Thromb Hemost. 2009. PMID: 19696042 Review.
-
Dabigatran etexilate, a thrombin inhibitor for the prevention of venous thromboembolism and stroke.Curr Opin Investig Drugs. 2007 Sep;8(9):758-68. Curr Opin Investig Drugs. 2007. PMID: 17729188 Review.
-
Dabigatran etexilate: a new oral thrombin inhibitor.Circulation. 2011 Apr 5;123(13):1436-50. doi: 10.1161/CIRCULATIONAHA.110.004424. Circulation. 2011. PMID: 21464059 Review. No abstract available.
-
Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.Pharmacol Ther. 2011 Feb;129(2):185-94. doi: 10.1016/j.pharmthera.2010.09.005. Epub 2010 Oct 12. Pharmacol Ther. 2011. PMID: 20920530 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
